Proteomics of breast cancer: principles and potential clinical applications (Q33245053)

24 July 2017

1 reference

title

Proteomics of breast cancer: principles and potential clinical applications (English)

1 reference

24 July 2017

1 reference

2

Daniel Birnbaum

1 reference

24 July 2017

François Bertucci

1

1 reference

PubMed ID

16733261

24 July 2017

Anthony Goncalves

series ordinal

3

1 reference

PubMed ID

16733261

24 July 2017

language of work or name

1 reference

29 May 2006

1 reference

Molecular & Cellular Proteomics

24 July 2017

1 reference

24 July 2017

5

1 reference

24 July 2017

1772-1786

1 reference

24 July 2017

10

1 reference

Gene expression profiling of cancer by use of DNA arrays: how far from the clinic?

24 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

A comparison of selected mRNA and protein abundances in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Protein profiles associated with survival in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

From genomics to proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Prevalence of KIT expression in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

The development of a cell array and its combination with laser-scanning cytometry allows a high-throughput analysis of nuclear DNA content

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Automated subcellular localization and quantification of protein expression in tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Technology insight: Identification of biomarkers with tissue microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Antibody arrays in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Profiling receptor tyrosine kinase activation by using Ab microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Protein microarrays: meeting analytical challenges for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

The N-pentenoyl protecting group for aminoacyl-tRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomics of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

A streamlined platform for high-content functional proteomics of primary human specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

SELDI-TOF-MS proteomics of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Molecular classification of breast carcinomas using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Signal transducer and activator of transcription-5 activation and breast cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Identification and validation of an ERBB2 gene expression signature in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Data management and analysis for gene expression arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600011-MCP200

10.1074/MCP.R600011-MCP200

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

16733261